Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT07059299 |
| Title | A Phase Ib Trial Evaluating the Safety and Activity of Neoadjuvant Combination of Tislelizumab Plus FLOT for Resectable Esophagogastric Adenocarcinoma (NeoTISLEGA) |
| Acronym | NeoTISLEGA |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | Institut fur Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest |
| Indications | |
| Therapies | |
| Age Groups: | senior | adult |
| Covered Countries | DEU |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Krankenhaus Nordwest GmbH Institut für Klinisch-Onkologische Forschung (IKF) | RECRUITING | Frankfurt | 60488 | Germany | Details | |
| Hämatologisch-Onkologische Praxis Eppendorf (hope) | NOT_YET_RECRUITING | Hamburg | 20249 | Germany | Details | |
| Universitätsklinikum Leipzig | NOT_YET_RECRUITING | Leipzig | 04103 | Germany | Details | |
| Klinikum rechts der Isar München der TU München | RECRUITING | München | 81675 | Germany | Details |